ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:
Solutie antistress!
Construieste poduri :)
Prinde pisica neagra :)
Sabin Gold Medal awarded to vaccine developer Dr. Albert Z. Kapikian
Albert Z. Kapikian, M D, of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National
Institutes of Health (NIH), was awarded the prestigious Albert B. Sabin Gold Medal at a ceremony on May 10, 2005. Cited for
his "extraordinary achievements in vaccinology," Dr. Kapikian is the 13th recipient of this recognition, awarded annually by
the Sabin Vaccine Institute to honor achievements by vaccinologists and infectious disease experts. In addition, John R. La
Montagne, Ph.D., who served as NIAID deputy director from 1998 until his death in November 2004, was posthumously recognized
at the ceremony, which was held in conjunction with the National Foundation for Infectious Diseases Eighth Annual Conference
on Vaccine Research in Baltimore, MD.
Dr. Kapikian's career of more than 47 years, with groundbreaking medical research contributions, is distinguished by the
development of the first licensed rotavirus vaccine.
"This well-deserved honor recognizes decades of creative research by Dr. Kapikian and his collaborators," says NIAID Director
Anthony S. Fauci, M.D. "Dr. Kapikian's scientific ingenuity, perseverance and leadership, notably in the development of
vaccines against rotavirus, have been remarkable."
"Albert Kapikian's contribution to mankind through the field of vaccines is truly extraordinary," says H.R. Shepherd, D.Sc.,
chairman of the Sabin Vaccine Institute. "It takes a great vision and dedication to achieve such progress for humanity."
In the 1950s Dr. Kapikian began studying the epidemiology and causes of various viral diseases. He is renowned for pioneering
studies using electron microscopy to discover and characterize viruses causing major diseases in humans. In 1972, Dr.
Kapikian identified the Norwalk virus, the first virus associated with acute epidemic gastroenteritis, gaining recognition as
"the father of human gastroenteritis virus research." In 1973, he and two colleagues identified the virus that causes
hepatitis A. He also became the first in the United States to detect and visualize human rotavirus, which was discovered by
others in Australia. He dedicated his efforts to studying this leading cause of severe diarrhea in infants and children,
which accounts for more than 500,000 deaths annually, predominantly in the developing world.
Dr. Kapikian led a nearly 25-year effort to develop an oral rotavirus vaccine. The NIAID team's rotavirus vaccine strategy
involved mating outer proteins from different human rotavirus strains with a monkey rotavirus that is attenuated (weakened)
for humans and combining the resulting hybrid viruses into one vaccine. From a single-strain vaccine in 1984, the vaccine was
made protective against the four most important clinical strains of rotavirus. In 1998, this vaccine became the first
rotavirus vaccine licensed in the United States.
Dr. Kapikian graduated from Cornell University Medical College in 1956 and in 1957 joined NIH as a commissioned officer of
the U.S. Public Health Service. In 1967 he was appointed head of NIAID's Epidemiology Section of the Laboratory of Infectious
Diseases, a position he holds today as a member of the Civil Service.
Dr. John La Montagne's 30-year career at NIH also was recognized at the ceremony. Dr. La Montagne contributed to
international efforts to fight emerging and re-emerging infectious diseases, including those related to biodefense. His
longtime colleague, Regina Rabinovich, M.D., M.P.H., director, Infectious Diseases, Bill and Melinda Gates Foundation,
presented the special award to his widow, Mary Elaine Elliot La Montagne.
NIAID is a component of the National Institutes of Health, an agency of the U.S. Department of Health and Human Services.
NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other
sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID
also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies.
News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.
Contact: NIAID News Office
niaidnews@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
http://www.niaid.nih.gov
Sabin Medalia de aur acordate vaccin dezvoltator Dr. Albert Z. Kapikian - Sabin Gold Medal awarded to vaccine developer Dr. Albert Z. Kapikian - articole medicale engleza - startsanatate